These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19077268)

  • 1. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.
    Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.
    Gao ZG; Verzijl D; Zweemer A; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    Biochem Pharmacol; 2011 Sep; 82(6):658-68. PubMed ID: 21718691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor.
    Göblyös A; Gao ZG; Brussee J; Connestari R; Santiago SN; Ye K; Ijzerman AP; Jacobson KA
    J Med Chem; 2006 Jun; 49(11):3354-61. PubMed ID: 16722654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species differences and mechanism of action of A
    Du L; Gao ZG; Paoletta S; Wan TC; Gizewski ET; Barbour S; van Veldhoven JPD; IJzerman AP; Jacobson KA; Auchampach JA
    Purinergic Signal; 2018 Mar; 14(1):59-71. PubMed ID: 29170977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.
    Gao ZG; Kim SG; Soltysiak KA; Melman N; IJzerman AP; Jacobson KA
    Mol Pharmacol; 2002 Jul; 62(1):81-9. PubMed ID: 12065758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor.
    Kim Y; de Castro S; Gao ZG; Ijzerman AP; Jacobson KA
    J Med Chem; 2009 Apr; 52(7):2098-108. PubMed ID: 19284749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
    Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
    Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine.
    Lambertucci C; Costanzi S; Vittori S; Volpini R; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1153-7. PubMed ID: 11562976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
    Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors.
    Yates L; Clark JH; Martin TJ; James S; Broadley KJ; Kidd EJ
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):191-200. PubMed ID: 16553647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A
    Gao ZG; Chen W; Gao RR; Li J; Tosh DK; Hanover JA; Jacobson KA
    Purinergic Signal; 2024 Oct; 20(5):559-570. PubMed ID: 38416332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.
    Kim SK; Gao ZG; Jeong LS; Jacobson KA
    J Mol Graph Model; 2006 Dec; 25(4):562-77. PubMed ID: 16793299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the A3 adenosine receptor affects cell cycle progression and cell growth.
    Brambilla R; Cattabeni F; Ceruti S; Barbieri D; Franceschi C; Kim YC; Jacobson KA; Klotz KN; Lohse MJ; Abbracchio MP
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):225-34. PubMed ID: 10731034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors.
    Varani K; Cacciari B; Baraldi PG; Dionisotti S; Ongini E; Borea PA
    Life Sci; 1998; 63(5):PL 81-7. PubMed ID: 9714428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.
    Baraldi PG; Cacciari B; Pineda de Las Infantas MJ; Romagnoli R; Spalluto G; Volpini R; Costanzi S; Vittori S; Cristalli G; Melman N; Park KS; Ji XD; Jacobson KA
    J Med Chem; 1998 Aug; 41(17):3174-85. PubMed ID: 9703463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action.
    Cohen S; Barer F; Bar-Yehuda S; IJzerman AP; Jacobson KA; Fishman P
    Mediators Inflamm; 2014; 2014():708746. PubMed ID: 25374446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.
    Gao ZG; Melman N; Erdmann A; Kim SG; Müller CE; IJzerman AP; Jacobson KA
    Biochem Pharmacol; 2003 Feb; 65(4):525-34. PubMed ID: 12566079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.